Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Origin Enterprises Plc Director's Dealing 2019

Jun 5, 2019

1973_dirs_2019-06-05_238483f0-8ac1-4fda-b835-3d32e12ea4be.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2297B

Origin Enterprises Plc

05 June 2019

Director's Shareholding

5 June 2019

Origin Enterprises plc ('Origin' or the 'Company') has been informed by Christopher Richards, a director of the Company, that 3,405 shares in the Company, previously held in his ISA, were transferred to an alternative account controlled by him on 4 June 2019.  There is no change in his overall beneficial shareholding which remains at 3,405 shares, representing approximately 0.003% of the issued share capital of the Company, excluding treasury shares.

ENDS

Enquiries:

Barbara Keane                           +353 (0)1 563 4911

Company Secretary

Origin Enterprises plc

About Origin Enterprises plc

Origin Enterprises plc is a focused Agri-Services group providing specialist On-Farm Agronomy Services, Digital Agricultural Services and the supply of crop technologies and inputs.  The Group has leading market positions in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania and Ukraine.  Origin is listed on the ESM and AIM markets of the Irish and London Stock Exchanges.

ESM ticker symbol:       OIZ

AIM ticker symbol:         OGN

Website:                       www.originenterprises.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHLIFEARSIEIIA